Intuitive Surgical insiders sold shares in September 2026
In September 2026, two Intuitive Surgical executives sold shares under Rule 10b5‑1 plans. Mark Brosius, executive vice president and chief manufacturing and supply chain officer, sold 48 shares for $17,140.93 on September 10‑11. Fredrik Widman, vice president, corporate controller, sold 1,089 shares for $407,765.16 on September 15.
Key points
- According to Form 4 (a filing that reports insider trading, period of report 2026‑09‑10), Mark Brosius reported two open market sales on September 10‑11.
- Both sales were made under a Rule 10b5‑1 plan (a preset selling schedule executives set up in advance), which is typically used to avoid trading on material non‑public information.
- If the sales are part of pre‑approved plans, they likely reflect liquidity needs rather than a negative view of the business, so investors may view them as neutral events.
What happened
According to Form 4 (a filing that reports insider trading, period of report 2026‑09‑10), Mark Brosius reported two open market sales on September 10‑11. He sold 48 shares for $17,140.93 at a weighted average price of $357.1027; after the transaction he held 764 shares.
According to Form 4 (period of report 2026‑09‑15), Fredrik Widman reported two types of transactions on September 15. First, he acquired 1,089 shares through option exercises (value $102,932.92), then sold 1,089 shares (value $407,765.16); after the sale he retained 1,026 shares and 1,086 derivative securities.
Intuitive Surgical insider sales in September 2026
Why it matters
Both sales were made under a Rule 10b5‑1 plan (a preset selling schedule executives set up in advance), which is typically used to avoid trading on material non‑public information. The plan does not guarantee insiders lacked such information.
When this may help investors
If the sales are part of pre‑approved plans, they likely reflect liquidity needs rather than a negative view of the business, so investors may view them as neutral events.
Risks and unknowns
The motivation for the sales, especially the large volume by Widman, remains unclear; a negative market perception could affect the share price, though this is not confirmed by other data.
What to watch
Watch subsequent Form 4 and Form 144 filings (a notice of a proposed sale) and changes in insider holdings to confirm whether trading continues under Rule 10b5‑1.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Intuitive Surgical
A notification in your browser or on your phone when we publish about Intuitive Surgical. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
